loadpatents
name:-0.019742965698242
name:-0.013520956039429
name:-0.0021390914916992
Tadesse; Dawit Patent Filings

Tadesse; Dawit

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tadesse; Dawit.The latest application filed is for "6,7-cyclicmorphinan derivatives and use thereof".

Company Profile
1.21.19
  • Tadesse; Dawit - Parlin NJ
  • Tadesse; Dawit - East Windsor NJ US
  • Tadesse; Dawit - Avenel NJ
  • Tadesse; Dawit - US
  • Tadesse; Dawit - Mississauga CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
6,7-cyclicmorphinan derivatives and use thereof
Grant 10,435,406 - Kassick , et al. O
2019-10-08
Substituted piperidin-4-amino-type compounds and uses thereof
Grant 10,118,927 - Brown , et al. November 6, 2
2018-11-06
6,7-cyclicmorphinan Derivatives And Use Thereof
App 20180265510 - Kassick; Andrew ;   et al.
2018-09-20
Triazine carboxamides as sodium channel blockers
Grant 10,000,475 - Tadesse , et al. June 19, 2
2018-06-19
Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
Grant 9,951,038 - Tadesse April 24, 2
2018-04-24
Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
Grant 9,598,447 - Tadesse , et al. March 21, 2
2017-03-21
Substituted Piperidin-4-amino-type Compounds And Uses Thereof
App 20160272640 - Brown; Kevin ;   et al.
2016-09-22
Quinazolin-4(3h)-one-type Piperidine Compounds And Uses Thereof
App 20160002203 - Tadesse; Dawit
2016-01-07
Triazine Carboxamides As Sodium Channel Blockers
App 20150353512 - Tadesse; Dawit ;   et al.
2015-12-10
Triazine carboxamides as sodium channel blockers
Grant 9,120,786 - Tadesse , et al. September 1, 2
2015-09-01
Heterocyclic aspartyl protease inhibitors
Grant 8,829,036 - Zhu , et al. September 9, 2
2014-09-09
Triazine Carboxamides As Sodium Channel Blockers
App 20140249128 - Tadesse; Dawit ;   et al.
2014-09-04
Heterocyclic aspartyl protease inhibitors
Grant 8,778,980 - Zhu , et al. July 15, 2
2014-07-15
Phosphorus-substituted Quinoxaline-type Piperidine Compounds And Uses Thereof
App 20140128346 - Tadesse; Dawit ;   et al.
2014-05-08
Heterocyclic aspartyl protease inhibitors
Grant 8,691,831 - Zhu , et al. April 8, 2
2014-04-08
Heterocyclic aspartyl protease inhibitors
Grant 8,691,833 - Zhu , et al. April 8, 2
2014-04-08
Heterocyclic Aspartyl Protease Inhibitors
App 20130018066 - Zhu; Zhaoning ;   et al.
2013-01-17
Heterocyclic Aspartyl Protease Inhibitors
App 20120276118 - Zhu; Zhaoning ;   et al.
2012-11-01
Heterocyclic Aspartyl Protease Inhibitors
App 20120231017 - ZHU; ZHAONING ;   et al.
2012-09-13
Heterocyclic Aspartyl Protease Inhibitors
App 20120231018 - Zhu; Zhaoning ;   et al.
2012-09-13
Heterocyclic aspartyl protease inhibitors
Grant 8,242,112 - Zhu , et al. August 14, 2
2012-08-14
Heterocyclic Aspartyl Protease Inhibitors
App 20110218194 - Zhu; Zhaoning ;   et al.
2011-09-08
Heterocyclic aspartyl protease inhibitors
Grant 7,973,067 - Zhu , et al. July 5, 2
2011-07-05
Heterocyclic Aspartyl Protease Inhibitors
App 20100292203 - Zhu; Zhaoning ;   et al.
2010-11-18
Heterocyclic aspartyl protease inhibitors
Grant 7,763,609 - Zhu , et al. July 27, 2
2010-07-27
Heterocyclic aspartyl protease inhibitors
Grant 7,700,603 - Zhu , et al. April 20, 2
2010-04-20
Heterocyclic Aspartyl Protease Inhibitors
App 20090258868 - Zhu; Zhaoning ;   et al.
2009-10-15
Heterocyclic aspartyl protease inhibitors
App 20080200445 - Zhu; Zhaoning ;   et al.
2008-08-21
Heterocyclic aspartyl protease inhibitors
App 20060111370 - Zhu; Zhaoning ;   et al.
2006-05-25
Electric arc furnace controller
Grant 6,274,851 - Mulcahy , et al. August 14, 2
2001-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed